Loading institutional data...
Loading institutional data...
Held by 641 of 5,944 reporting institutions (98th percentile) — extremely crowded.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
How management deployed cash over 10 years — and what it earned on reinvestment.
A cash-return story — far more went to shareholders than back into the business (mature, low-reinvestment).
Reinvestment has been productive — operating income grew well per dollar put in. Current ROIC on all capital: 19%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
Ranked against 633 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LTM | $33.13T | — | — | — | — | — | — | — | — | — | 160 |
| CAT | $405.3B | 46.3× | 32.2× | 6.0× | 4.3% | 33.8% | 13.1% | 41.7% | 15.4% | 2.7× | 3,616 |
| GE | $399.8B | 46.8× | — | 8.7× | 18.5% | — | 19.0% | 46.6% | 22.2% | — | 3,077 |
| RTX | $298.4B | 44.8× | 21.3× | 3.4× | 9.7% | — | 7.6% | 10.3% | 10.3% | 0.0× | 3,277 |
| ABBNY | $187.8B | 50.7× | 33.5× | 5.8× | 9.5% | 34.8% | 11.9% | 28.5% | 20.4% | 0.9× | 48 |
| UNP | $175.3B | 24.7× | 16.7× | 7.2× | 1.1% | — | 29.1% | 38.7% | 14.2% | 2.6× | 2,648 |
| ETN | $173.5B | 42.8× | — | 6.3× | 10.3% | 37.6% | 14.9% | 21.0% | 13.9% | — | 2,398 |
| DE | $165.5B | 33.1× | — | 3.6× | -11.7% | — | 11.0% | 19.4% | 12.6% | — | 2,491 |
| HON | $157.6B | 33.7× | 18.9× | 4.2× | 7.8% | 36.9% | 12.6% | 34.0% | 9.8% | 3.6× | 2,694 |
| HTHIF | $153.6B | 0.7× | — | 0.0× | 3.9% | 25.2% | 2.6% | 16.6% | 7.4% | — | 2 |
| LMT | $132.3B | 26.9× | 17.0× | 1.8× | 5.6% | 10.2% | 6.7% | 74.6% | 18.4% | 2.4× | 2,807 |
| PH | $127.9B | 36.8× | 28.7× | 6.4× | -0.4% | 36.9% | 17.8% | 25.8% | 16.7% | 1.6× | 1,845 |
| HWM | $117.0B | 78.5× | 51.2× | 14.2× | 11.1% | — | 18.3% | 28.2% | 18.4% | 1.2× | 1,399 |
| ADP | $109.5B | 27.1× | — | 5.3× | 7.1% | 46.0% | 19.8% | 65.9% | 40.1% | — | 2,179 |
| TT | $107.8B | 37.3× | 26.5× | 5.1× | 7.5% | — | 13.7% | 34.0% | 22.1% | 1.1× | 1,658 |
| VRT | $106.3B | 81.5× | 50.3× | 10.4× | 27.7% | 36.3% | 13.0% | 33.8% | 19.5% | 1.4× | 1,748 |
| GD | $103.9B | 24.9× | 18.1× | 2.0× | 10.1% | — | 8.0% | 16.4% | 12.5% | 1.3× | 2,123 |
| PWR | $102.2B | 100.4× | 50.3× | 3.6× | 20.3% | 15.0% | 3.7% | 11.7% | 11.7% | 0.0× | 1,659 |
| JCI | $100.1B | 30.6× | — | 4.2× | 2.8% | 36.4% | 13.9% | 25.5% | 14.4% | — | 1,487 |
| MMM | $96.6B | 30.4× | 18.4× | 3.9× | 1.5% | 39.9% | 13.0% | 69.1% | 18.8% | 2.1× | 2,051 |
| CSX | $95.1B | 33.2× | 15.3× | 6.8× | -3.1% | — | 20.5% | 22.0% | 22.0% | — | 1,791 |
| EMR | $91.4B | 40.2× | — | 5.1× | 3.0% | 52.8% | 12.7% | 11.3% | 6.9% | — | 2,112 |
| UPS | $91.4B | 16.4× | 10.1× | 1.0× | -2.6% | — | 6.3% | 34.3% | 13.8% | 2.2× | 2,025 |
| WM | $90.4B | 33.5× | 12.7× | 3.6× | 14.2% | 40.4% | 10.7% | 27.1% | 25.3% | 0.1× | 2,262 |
| CMI | $89.7B | 31.7× | 16.9× | 2.7× | -1.3% | 25.3% | 8.8% | 23.9% | 23.9% | — | 1,877 |
| LECO | $15.3B | 30.0× | 20.0× | 3.6× | 5.6% | 36.2% | 12.3% | 35.4% | 18.8% | 1.6× | 641 |
Peers = companies sharing LECO's sector (Industrials) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
Solve the discounted cash flow backwards, then stress-test the assumptions.
This company doesn't have positive free cash flow, so a reverse DCF can't be run.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Cash-conversion data unavailable. Lower/negative accruals = higher quality (Sloan).
Comfortably covers interest; leverage falling year-over-year.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
Free-cash-flow coverage unavailable. Last year: $168M dividends + $338M buybacks = $507M returned.
9 consecutive years of dividend increases · 10%/yr.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
EOD close · as of 2026-08-05 · 15d old
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.23B 100.0% | $4.01B 100.0% | $4.19B 100.0% | $3.76B 100.0% | $3.23B 100.0% | $2.66B 100.0% | $3.00B 100.0% | $3.03B 100.0% | $2.62B 100.0% | $2.27B 100.0% |
| Cost of Revenue | $2.70B 63.8% | $2.54B 63.3% | $2.73B 65.0% | $2.48B 65.9% | $2.17B 67.0% | $1.78B 67.2% | $2.00B 66.5% | $2.00B 66.0% | $1.75B 66.7% | $1.49B 65.4% |
| Cost of Products | — | — | — | — | — | — | — | $2.00B 66.0% | $1.75B 66.7% | $1.49B 65.4% |
| Gross Profit | $1.53B 36.2% | $1.47B 36.7% | $1.47B 35.0% | $1.28B 34.1% | $1.07B 33.0% | $871.3M 32.8% | $1.01B 33.5% | $1.03B 34.0% | $875.1M 33.3% | $786.6M 34.6% |
| Research & Development | $85.5M 2.0% | $81.8M 2.0% | $71.2M 1.7% | $63.2M 1.7% | $56.0M 1.7% | $51.4M 1.9% | $56.8M 1.9% | $54.2M 1.8% | $47.9M 1.8% | $44.7M 2.0% |
| Selling, General & Admin | $798.0M 18.9% | $780.6M 19.5% | $758.9M 18.1% | $656.6M 17.5% | $597.1M 18.5% | $543.8M 20.5% | $621.5M 20.7% | $627.7M 20.7% | $541.2M 20.6% | $468.6M 20.6% |
| Operating Income | $718.1M 17.0% | $636.5M 15.9% | $717.8M 17.1% | $612.3M 16.3% | $461.7M 14.3% | $282.1M 10.6% | $370.9M 12.4% | $375.5M 12.4% | $376.9M 14.4% | $283.6M 12.5% |
| Interest Expense | $58.4M 1.4% | $52.9M 1.3% | $51.1M 1.2% | $31.1M 0.8% | $23.8M 0.7% | $24.0M 0.9% | $25.9M 0.9% | $24.5M 0.8% | $24.2M 0.9% | $19.1M 0.8% |
| Interest & Investment Income | $6.8M 0.2% | $10.1M 0.3% | $6.8M 0.2% | $1.6M 0.0% | $1.6M 0.0% | $2.0M 0.1% | $2.5M 0.1% | $6.9M 0.2% | $4.8M 0.2% | $2.1M 0.1% |
| Other Income (Expense), net | $9.0M 0.2% | $473K 0.0% | $13.4M 0.3% | $10.0M 0.3% | -$114.5M -3.5% | $3.9M 0.1% | $21.0M 0.7% | $10.7M 0.4% | $8.7M 0.3% | $10.8M 0.5% |
| Pretax Income | $675.5M 16.0% | $594.1M 14.8% | $686.9M 16.4% | $592.8M 15.8% | $325.0M 10.0% | $264.0M 9.9% | $368.5M 12.3% | $368.7M 12.2% | $366.2M 14.0% | $277.4M 12.2% |
| Income Tax Expense | $154.9M 3.7% | $128.0M 3.2% | $141.6M 3.4% | $120.6M 3.2% | $48.4M 1.5% | $57.9M 2.2% | $75.4M 2.5% | $81.7M 2.7% | $118.8M 4.5% | $79.0M 3.5% |
| Net Income | $520.5M 12.3% | $466.1M 11.6% | $545.2M 13.0% | $472.2M 12.6% | $276.6M 8.6% | $206.1M 7.8% | $293.1M 9.8% | $287.1M 9.5% | $247.5M 9.4% | $198.4M 8.7% |
| Per Share | ||||||||||
| EPS (Basic) | $9.39 | $8.23 | $9.50 | $8.14 | $4.66 | $3.46 | $4.73 | $4.42 | $3.76 | $2.94 |
| EPS (Diluted) | $9.32 | $8.15 | $9.37 | $8.04 | $4.60 | $3.42 | $4.68 | $4.37 | $3.71 | $2.91 |
| Weighted Avg Shares (Basic) | 55.4M | 56.6M | 57.4M | 58.0M | 59.3M | 59.6M | 62.0M | 64.9M | 65.7M | 67.5M |
| Weighted Avg Shares (Diluted) | 55.9M | 57.2M | 58.2M | 58.7M | 60.1M | 60.2M | 62.7M | 65.7M | 66.6M | 68.2M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $309M covers the $144M due within a year 2.1× over. Scheduled principal only (excludes interest & revolver draws). As of 2025-12-31 (10-K).
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Interest is easily covered by operating profit. Effective rate ~4.5% on $1.3B of debt.
Cash of $309M fully covers short-term debt of $144M.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
EOD close · as of 2026-08-05
Nothing notable to watch.
No material risks flagged.
Where each multiple sits in its own 14-yr range · 98th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 14-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
High operating leverage: profit moved 2.3× as fast as sales — great in an upturn, painful in a downturn.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 66.0 | 66.5 | 67.2 | 67.0 | 65.9 | 65.0 | 63.3 | 63.8 |
| Gross Profit | 34.0 | 33.5 | 32.8 | 33.0 | 34.1 | 35.0 | 36.7 | 36.2 |
| R&D | 1.8 | 1.9 | 1.9 | 1.7 | 1.7 | 1.7 | 2.0 | 2.0 |
| SG&A | 20.7 | 20.7 | 20.5 | 18.5 | 17.5 | 18.1 | 19.5 | 18.9 |
| Operating Income | 12.4 | 12.4 | 10.6 | 14.3 | 16.3 | 17.1 | 15.9 | 17.0 |
| Income Tax | 2.7 | 2.5 | 2.2 | 1.5 | 3.2 | 3.4 | 3.2 | 3.7 |
| Net Income | 9.5 | 9.8 | 7.8 | 8.6 | 12.6 | 13.0 | 11.6 | 12.3 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on LECO: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.